Summary
The aims in management of an arthropathy are to relieve symptoms, preserve function, and control the disease process. Drugs are an important, although not the only, part of any therapeutic regimen enabling us to achieve these aims.
Although each individual requires a unique strategy, there is a logical progression from first-line agents to second-line agents. Third-line agents and experimental methods are reserved for aggressive or life-threatening disease. The choice of agent in each group is personal preference, but many agents have high adverse effect profiles, and close moni-toring is essential.
Similar content being viewed by others
References
Anon. Fish oils in rheumatoid arthritis. Lancet 2: 720–721, 1987
Ansell BM, Hall MA, Ribero S. A comparative study of gold and penicillamine in seropositive juvenile chronic arthritis. Abstract. Annals of the Rheumatic Diseases 40: 522–523, 1981
Belch JJF, Madhok R, McArdler B, McLaughlin K, Kluft C, et al. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double-blind study of stanozolol. Quarterly Journal of Medicine 58: 19–27, 1986
Bhatt-Sanders D. Acupuncture for rheumatoid arthritis: analysis of the literature. Seminars in Arthritis and Rheumatism 14: 225–231, 1985
Bird HA, Ring EFJ, Bacon PA. A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Annals of the Rheumatic Diseases 38: 36–39, 1979
Bird HA, Wright V. Applied drug therapy of the rheumatic diseases, John Wright, Bristol, 1982
Boers M, Van Rijthoven AWAM, Goei The HS, Dijkmans BAC, Cats A. Serum creatinine levels two years later: follow-up of a placebocontrolled trial of cyclosporin in rheumatoid arthritis. Abstract. British Journal of Rheumatology 26 (Suppl. 2): 3, 1987
Bunch TW, O’Duffy JD. Disease-modifying drugs for progressive rheumatoid arthritis. Mayo Clinic Proceedings 55: 161–179, 1980
Bunch TW, O’Duffy JD, Tompkins RB, O’Fallon WM. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis and Rheumatism 27: 267–276, 1984
Byron MA, Kirwan JR. Corticosteroids in rheumatoid arthritis: is a trial of their disease-modifying potential feasible? Annals of the Rheumatic Diseases 46: 171–173, 1986
Cannon GW, Jackson CG, Samuelson CO, Ward JR, Williams HJ, et al. Chlorambucil therapy in rheumatoid arthritis: clinical experience in 28 patients and literature review. Seminars in Arthritis and Rheumatism 15: 106–118, 1985
Chaffman M, Brogden RN, Heel RC, Speight TM, Avery GS. Auranofin: a preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis. Drugs 27: 378–424, 1984
Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of cyclophosphamide in rheumatoid arthritis. New England Journal of Medicine 283: 833–889, 1970
Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis and Rheumatism 16: 353–358, 1973
Currey HLF, Harris J, Mason RM. Comparison of azathioprine, cyclophosphamide and gold in the treatment of rheumatoid arthritis. British Medical Journal 3: 763–766, 1974
Dodd MJ, Griffiths ID, Thompson M. Adverse reactions to D-penicillamine after gold toxicity. British Medical Journal 280: 1498–1500, 1980
Dorwart BB, Gall EP, Schumacher HR, Krauser RE. Crysotherapy in psoriatic arthropathy: efficacy and toxicity compared to rheumatoid arthritis. Arthritis and Rheumatism 21: 573–575, 1978
Dwosh IL, Stein HB, Urowitz MB, Smythe HA, Hunter T, et al. Azathioprine in early rheumatoid arthritis: comparison with gold and chloroquine. Arthritis and Rheumatism 20: 685–692, 1977
Emery P, Gibson T. A double-blind study of the simple analgesic nefopam in rheumatoid arthritis. British Journal of Rheumatology 25: 72–76, 1986
European League against Rheumatism. Proceedings of the International Symposium on Levamisole in Rheumatoid Arthritis, Antwerp, June 23, 1978. Journal of Rheumatology 5 (Suppl. 4), 1978
Fike MC. How occupational therapy can help your arthritis patient. Journal of Musculoskeletal Medicine 1: 51–58, 1984
Ford PM. HLA antigens and drug toxicity in rheumatoid arthritis. Journal of Rheumatology 11: 259–261, 1984
Furst DE. Mechanism of action, pharmacology, clinical efficacy and side-effects of auranofin: an orally administered gold compound for the treatment of rheumatoid arthritis. Pharmacotherapy 3: 284–298, 1983
Grindulis KA, Nichol FE, Oldham R. Phenytoin in rheumatoid arthritis. Journal of Rheumatology 13: 1035–1039, 1986
Hall CL, Jawad S, Morrison PR, MacKenzie JC, Bacon PA, et al. Natural course of penicillamine nephropathy: a long term study of 33 patients. British Medical Journal 296: 1083–1086, 1988
Hall ND, Bird HA, Ring EFJ, Bacon PA. A combined clinical and immunological assessment of four cyclophosphamide regimes in rheumatoid arthritis. Agents and Actions 9: 97–102, 1979
Hanly JG, Hasson J, Mariarly M, Barry C, Molony J, et al. Lymphoid irradiation in intractable rheumatoid arthritis. Arthritis and Rheumatism 29: 16–25, 1986
Hobbs HE, Sarsby A, Freeman A. Retinopathy following chloroquine therapy. Lancet 2: 478–480, 1959
Hunter T, Urowitz MB, Gordon DA, Smythe HA, Ogryzlo MA. Azathioprine in arthritis: a long-term follow-up study. Arthritis and Rheumatism 18: 15–20, 1975
Huskisson EC. Antirheumatic drugs. Clinics in Rheumatic Diseases 5: 357–736, 1979
Huskisson EC, Doyle DV, Lanham JG. Drug treatment of osteoarthritis. Clinics in Rheumatic Diseases 11: 421–431, 1985
Joint Committee of the Medical Research Council and the Nuffield Foundation. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases 18: 173–187, 1959
Joint Committee of the Medical Research Council and the Nuffield Foundation. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases 19: 331–337, 1960
Karsh J, Klippel JH, Plotz PH, Wright DG, Flye W, et al. Lymphoparesis in rheumatoid arthritis: a randomised trial. Arthritis and Rheumatism 23: 701–702, 1980
Karsh J, Wright DG, Klippel JH, Decber JL, Deisseroth AB, et al. Lymphocyte depletion by continuous flow centrifugation in rheumatoid arthritis. Arthritis and Rheumatism 22: 1055–1059, 1979
Lunkkainen R, Isonaki H, Kojarder A. Effect of gold treatment on the progression of erosions in rheumatoid arthritis patients. Scandinavian Journal of Rheumatology 6: 123–127, 1977
Malaise MG, Hauwaert C, Franchimont P, Danncskidd-Semsoe B, Bach-Anderson R, et al. Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. Lancet 1: 832–836, 1985
Martin MFR, Surrall KE, McKenna F, Dixon JS, Bird HA, et al. Captopril: a potential new treatment for rheumatoid arthritis. Lancet 1: 1325–1327, 1984
Mason RM, Currey HLF, Barnes CG. Azathioprine in rheumatoid arthritis. British Medical Journal 1: 420–421, 1969
Mattingly S. Palindromic Rheumatism. Annals of the Rheumatic Diseases 25: 307–316, 1966
Multicentre Trial Group. Controlled trial of D-penicillamine in severe rheumatoid arthritis. Lancet 1: 275–280, 1973
Multicentre Study Group. Levamisole in rheumatoid arthritis. Lancet 2: 1007–1012, 1978
Nacarro AH. Physical therapy in the management of rheumatoid arthritis. Clinical Rheumatology 1: 125–130, 1983
Needs CJ, Brooks P. Anti-rheumatic medication in pregnancy. British Journal of Rheumatology 24: 282–290, 1985
Nelson AM, Carn DL. Glucocorticoids in rheumatic disease. Mayo Clinic Proceedings 55: 758–769, 1980
Neumann VC, Grindulis KA, Hubball S, McCankey B, Wright V. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial, British Medical Journal 287: 1099–1102, 1983
Neumann V, Hopkins R, Dixon J, Walkins A, Bird H, et al. Combination therapy with pulsed methylprednisolbne in rheumatoid arthritis. Annals of the Rheumatic Diseases 44: 747–757, 1985
Owen ET, Cohen ML. Methotrexate in Reiter’s disease. Annals of the Rheumatic Diseases 38: 48–50, 1979
Panayi GS, Wooley P, Batchelor JR. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. British Medical Journal 2: 1326–1328, 1978
Paulus HE, Macheder HI, Levine S, Yu DTY, MacDonald NS. Lymphocytic involvement in rheumatoid arthritis: studies during thoracic duct drainage. Arthritis and Rheumatism 20: 1249–1262, 1977
Proceedings. Advances in arthritis therapy: experience with methotrexate, Anaheim, June 8, 1985. Journal of Rheumatology 12 (Suppl. 12), 1985
Pullar T, Hunter JA, Capell HA. Sulphasalazine in rheumatoid arthritis: a double-blind comparison of sulphasalazine with placebo and sodium aurothiomalate. British Medical Journal 287: 1102–1104, 1983
Rainsford K. Side effects of anti-inflammatory/analgesic drugs: epidemiology and gastrointestinal tract. Trends in Pharmacological Sciences, April 1–4, 1984
Research Sub-Committee of the Empire Rheumatism Council. Gold therapy in rheumatoid arthritis: final report of a multicentre controlled trial. Annals of the Rheumatic Diseases 20: 315–334, 1961
Richter MB, Kinsella P, Corbett M. Gold in psoriatic arthropathy. Annals of the Rheumatic Diseases 39: 279–280, 1980
Rotherwell RS, Davies P, Gardon PA, Dasgupta MK, Johny KV, et al. A controlled study of plasma exchange in the treatment of severe rheumatoid arthritis. Arthritis and Rheumatism 23: 785–790, 1980
Rynes RI. Antimalarial treatment of rheumatoid arthritis. Journal of Rheumatology 12: 657–659, 1985
Rynes RI, Krohel G, Falbo A, Reuniecke RD, Wolfe B, et al. Ophthamological safety of long-term hydroxychloroquine treatment. Arthritis and Rheumatism 22: 832–836, 1979
Sheppeard H, Ward DJ. Intra-articular osmic acid in rheumatoid arthritis: five years experience. Rheumatology and Rehabilitation 19: 25–29, 1980
Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, et al. Gold salts in the treatment of rheumatoid arthritis: a double-blind study. Annals of Internal Medicine 80: 21–26, 1974
Simon LS, Mills JA. Non-steroidal anti-inflammatory drugs. Part 1. New England Journal of Medicine 302: 1179–1188, 1980
Smyth CJ, Bartholomew BA, Mills BM. Cyclophosphamide therapy for rheumatoid arthritis. Archives of Internal Medicine 135: 789–793, 1975
Spalton D. Chloroquine and the eye. British Journal of Clinical Practice 41 (Suppl. 52): 50–55, 1987
Symoens J, Schuermans Y. Levamisole. Clinics in Rheumatic Diseases 5: 603–629, 1979
Symposium on Radioactive Colloids in the Treatment of Arthritis. Annals of the Rheumatic Diseases 32 (Suppl.), 1973
Trentham DE, Belli JA, Anderson RJ, Buckley JA, Goetzl EJ, et al. Clinical irradiation in refractory rheumatoid arthritis. New England Journal of Medicine 305: 976–982, 1981
Tugwell P, Bennett K, Gent M. Methotrexate in rheumatoid arthritis. Annals of Internal Medicine 107: 358–366, 1987
Van Rijthoven AWAM, Dijkmans BAC, Goei The HS, Hemans J, Montrar-Beckers ZLMB, et al. Cyclosporin treatment for rheumatoid arthritis: a placebo-controlled, double-blind multicentre study. Annals of the Rheumatic Diseases 45: 726–731, 1986
Veo T, Taraba S, Taminaga Y, Ogana H, Schwarmi T. The effect of thoracic duct drainage in lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis. Arthritis and Rheumatism 22: 1405–1412, 1979
Wallace DJ, Goldfinger D, Galti R, Lowe C, Fan P, et al. Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis. Arthritis and Rheumatism 22: 703–710, 1979
Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. New England Journal of Medicine 312: 818–820, 1985
Wilkins RF, Williams HJ, Ward JR. Egger MJ, Reading JC, et al. Randomised double-blind placebo-controlled trial of low dose pulse methotrexate in psoriatic arthritis. Arthritis and Rheumatism 27: 376–381, 1984
Williams HJ, Wilkins RF, Samuelson CO, Alarcon GS, Guttadauria M, et al. Comparison of low dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. Arthritis and Rheumatism 28: 721–730, 1985
Winchester R, Bernstein DH, Fischer HD, Enlow R, Solomon G. The co-occurrence of Reiter’s syndrome and acquired immunodeficiency. Annals of Internal Medicine 106: 19–26, 1987
Wong DG, Spence JD, Lamki L, Freeman D, McDonald JWD. Effect of non-steroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics. Lancet 1: 997–1001, 1986
Woodland J, Chaput de Saintonge DM, Evans SJW, Sharman VL, Currey HLF. Azathioprine in rheumatoid arthritis: a double-blind study of full versus half doses versus placebo. Annals of the Rheumatic Diseases 40: 355–359, 1981
Wright V. Oral gold for rheumatoid arthritis. British Medical Journal 289: 858–859, 1984
Zvaifler NJ. Antimalarial treatment of rheumatoid arthritis. Medical Clinics of North America 52: 759–764, 1968
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolfe, C.S., Hughes, G.R.V. The Optimum Management of Arthropathies. Drugs 36, 370–381 (1988). https://doi.org/10.2165/00003495-198836030-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198836030-00007